or Try an Advanced Search...

    Tyrosine Kinase Receptors Stocks List

    Symbol Grade Name % Change
    BDTX A Black Diamond Therapeutics, Inc. 9.49
    BPMC A Blueprint Medicines Corporation 13.32
    BBIO D BridgeBio Pharma, Inc. 1.33
    DCPH A Deciphera Pharmaceuticals, Inc. 0.01
    ELVN A Enliven Therapeutics, Inc. 10.47
    ERAS D Erasca, Inc 0.72
    FUSN A Fusion Pharmaceuticals Inc. 0.19
    MACK A Merrimack Pharmaceuticals, Inc. 0.13
    NUVL C Nuvalent, Inc. 1.44
    PRLD D Prelude Therapeutics Incorporated 5.10
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biopharmaceutical Clinical Development Breast Cancer Epidermal Growth Factor Receptor Fibroblast Growth Factor Receptor Her2 Her2/Neu Protein Kinase Inhibitor Treatment Of Breast Cancer Acute Myeloid Leukemia Antibodies Biology Bladder Cancer Cell Biology Chemical Compounds Drugs Fibroblast Growth Factor Insulin Medicine

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase Receptors stocks.

    Symbol Grade Name Weight
    MRGR B ProShares Merger ETF 2.68
    CNCR C Loncar Cancer Immunotherapy ETF 2.51
    MNA F IQ Merger Arbitrage ETF 2.5
    BBP C BioShares Biotechnology Products Fund 1.89
    LABD C Direxion Daily S&P Biotech Bear 3X Shares 1.66
    View all Tyrosine Kinase Receptors ETFs...
    Compare ETFs
    Compare BBP to LABD Compare CNCR to MNA Compare MRGR to BBP

        Tyrosine Kinase Receptors Stocks Recent News

        Date Stock Title
        May 2 FUSN Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 BBIO BridgeBio Pharma GAAP EPS of -$0.20 beats by $0.31, revenue of $211.12M beats by $127.34M
        May 2 BBIO BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
        May 2 BPMC Blueprint Medicines  GAAP EPS of $1.40 beats by $3.05, revenue of $96.12M beats by $14.68M
        May 2 BPMC Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
        May 2 BBIO BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline
        May 2 BBIO BridgeBio spinout launches with $200M for KRAS cancer drugs
        May 1 BPMC Blueprint Medicines Q1 2024 Earnings Preview
        May 1 BBIO Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
        Apr 30 MACK Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq
        Apr 30 MACK Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution
        Apr 30 BPMC Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
        Apr 30 DCPH ONO to acquire Deciphera Pharmaceuticals in $2.4B deal
        Apr 30 DCPH Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
        Apr 29 DCPH Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday?
        Apr 29 DCPH Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
        Apr 29 DCPH Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
        Apr 29 DCPH Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
        Apr 29 DCPH Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
        Apr 29 DCPH Deciphera Pharmaceuticals Is Being Acquired and the Stock Soars 72%
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biopharmaceutical Clinical Development Protein Kinase Inhibitor Antibodies Blastoma Breast Cancer Epidermal Growth Factor Receptor Glioblastoma Glioblastoma Multiforme Her2 Her2/Neu Insulin Medicine Solid Tumors Treatment Of Breast Cancer Advanced Breast Cancer Advanced Cancer Antineoplastic Drugs Biology
        Tyrosine Kinase Receptors

        Tyrosine kinase receptors are a type of cell surface receptor that binds to specific molecules and activates a signal transduction pathway inside the cell. They are involved in a wide range of cellular processes, including cell growth, differentiation, and migration. They are also involved in the regulation of the immune system and in the development of cancer.

        Browse All Tags